VOPROSY MEDITSINSKOI KHIMII (ISSN 0042-8809)

Platelet glycosaminoglycans in paraproteinemic hemoblastoses

   
Kharchenko M.F., Bitiukova E.S., Bessmel'tsev S.S.
PubMed Id: 8619307
Year: 1995  Volume: 41  Issue: 6  Pages: 55-58
The content and composition of platelet glycosaminoglycans (GAG) were studied in 24 patients with paraproteinemic hemoblastoses (22 patients with myelomic disease and 2 with Waldenstrom's disease). According to the GAG levels, the patients were divided into 2 groups: 1) 6 patients with its higher levels (181 +/- 8 micrograms of uronic acids per 100 mg of acetone-dried cells) and 2) 18 patients with its close-to-normal levels (129 +/- 4 micrograms per 100 mg of the cells). Marked manifestations of hemorrhagic diathesis were found in 5 patients in Group 1 and in 1 in Group 2. Chondroitin sulfate was demonstrated to prevalent in the platelets of patients with paraproteinemic hemoblastoses, as in those of healthy persons. There was GAG electrophoretic profile depletion due to the reduced number of minor components of non- and low-sulfated GAG in 14 patients. It is suggested that the changes detected in the content and composition of GAG may contribute to platelet dysfunction in these diseases
Download PDF:
Citation:

Kharchenko, M. F., Bitiukova, E. S., Bessmel'tsev, S. S. (1995). Platelet glycosaminoglycans in paraproteinemic hemoblastoses. Voprosy meditsinskoi khimii, 41(6), 55-58.
References
 2002 (vol 48)
 2001 (vol 47)
 2000 (vol 46)
 1999 (vol 45)
 1998 (vol 44)
 1997 (vol 43)
 1996 (vol 42)
 1995 (vol 41)
 1994 (vol 40)
 1993 (vol 39)
 1992 (vol 38)
 1991 (vol 37)
 1990 (vol 36)
 1989 (vol 35)
 1988 (vol 34)
 1987 (vol 33)
 1986 (vol 32)
 1985 (vol 31)